Hear From an Expert:

Q&A with Dr. Rana Zeine: Medical Cannabis Research for Cancer, MS, Epilepsy & More

By IGI Global on Jun 12, 2024
0Dr. Rana Zeine, with three decades of experience in primary research on brain diseases and cancer, along with eight years in secondary research on the effects of medical cannabis, is one of the lead experts behind the book Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases (ISBN: 9781668456521). Since the book's release, Dr. Zeine has spoken about her research at several events. Most recently, she was a Guest Speaker at the SALIHIN Corporate Centre in Kuala Lumpur, Malaysia, providing insights and background related to the book. See below, where she answers some of our questions about the conception of this
research book.
Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
Profs. Rana R. Zeine and Brian W. Teasdale
© 2023 | 405 pgs. | ISBN13: 9781668456521
  • Covers Topics such as Medical Cannabis, Neurobiology of Cannabinoids, and Therapeutic Intervention
  • Ideal for Medical Professionals, Pharmacists, and
    Hospital Administrators
  • Indexed In: SCOPUS
Quick Links
Bibliographic Information
Pricing & Purchase Options
Table of Contents
Recommend to Library
Access Full Text

Dr. Rana R. Zeine Answers Our Questions

What was the driving force or motivation for starting your book?

Dr. Zeine: The driving force for starting this book was the anticipation that president Joe Biden was planning to legalize the use of medical cannabis in the USA. IGI Global publisher envisioned creating a scientific book that presents the latest knowledge on the properties and effects of medical cannabis available from around the world.
What specific problems does your book address?
Dr. Zeine: The book specifically addresses the efficacy and mechanisms of action of medical cannabis for treatment of neurodegenerative diseases, epilepsy, demyelinative diseases and cancers.

How does Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases provide a solution to these problems?

Dr. Zeine: The book provides an overview of the medicinal uses of cannabis throughout history, the biochemical properties of the endocannabinoids and phytocannabinoids found in Cannabis and cannabimimetic plants, analysis of the clinical benefits observed in patients and experimental models, synthesis of the cellular and molecular mechanisms implicated in anti-inflammatory, anti-seizure, anti-tumor, neuroprotective, regenerative and remyelinative effects of cannabinoids.

What do you think about publishing this book changes about the field of study?

Dr. Zeine: This is the first scientific book about medical cannabis in the modern era of medicine. Publishing this book helps governments around the world to recognize the potential benefits of cannabis in modern medicine and guides future pharmacologic research to develop new medicines for healing human diseases. It is a rich resource for scientists who wish to write grants to seek funding for academic research, for physicians who wish to prescribe cannabis, and for publishers who plan to include medical cannabis in textbooks of physiology, biochemistry, pharmacology, pathology, immunology, neurology, psychiatry and oncology.

How does your professional background support your ability to be an authority on this book's coverage?

Dr. Zeine: Prior to working on this book, I had published systematic review articles on the benefits of medical cannabis in movement disorders, including Parkinson’s and Huntington’s diseases, and in the inflammatory demyelinative disease Multiple Sclerosis. My professional background includes specialization in pathology and neuropathology, and basic medical research in neuroimmunology and cancer pathology.

What special organizations, or other professional affiliations give you experience in the areas covered by this book?

Dr. Zeine: During my career, I have been involved with various specialized organizations, which have helped me gain expertise in the topics covered in this book. I have been a member of the Society of Experimental Biology & Medicine since 2023 and have actively participated in the International Society of Neuroimmunology since 2019. These memberships have given me valuable insights into these fields' latest research and developments. Additionally, my affiliation with the International Higher Education Teaching & Learning Association since 2011 has improved my teaching skills, making me more effective at sharing knowledge. Having been a member of the International Society of Neuropathologists since 2004 and the United States and Canadian Academy of Pathology since 2000, I have developed a thorough understanding of neuropathology and related subjects, contributing to my comprehensive knowledge of the topics covered in this book.

About the Editors
665d587f-23df-4a9b-8275-c1d8c0610131Rana Zeine, MD, PhD, MBA is Adjunct Faculty at Kean University Department of Biological Sciences (1/2020-present), and Union College of Union County STEM-Biology (9/2023-present) Union, New Jersey, USA, and also Visiting Professor III at Chamberlain University College of Nursing (10/2021-present), North Brunswick, NJ, USA. She teaches Immunology, Microbiology, Biological Aspects of Aging, Genetics, Anatomy & Physiology, Human Biology Lab, Biology of Cancer, Independent Research, Senior Seminars and formerly taught Pathology at the Saint James School of Medicine. Dr. Zeine received her B.S. in Biology ’83, Teaching Diploma '83, and M.D. ’87 degrees from the American University of Beirut (AUB) in Lebanon. She completed elective rotations in neurogenetics and neuropediatrics at The Massachusetts General Hospital and Boston Children's Hospital, Harvard Medical School, '86, Boston, MA, USA. Dr. Zeine was awarded Multiple Sclerosis Society of Canada fellowships and earned her Ph.D. ‘93 degree in Experimental Medicine from McGill University, Montreal, QC, Canada. She completed her residency in Anatomic Pathology '00-'02 and subspecialty fellowship in Neuropathology '02-'04 at the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NYC, USA. Dr. Zeine also earned an M.B.A. ’12, concentration Human Resources Management, with Distinction, from Keller Graduate School of Management of DeVry College of New York, NYC, USA. She is accredited (’21) in Organizational Culture (OCI) and Organizational Effectiveness (OEI) inventories by Human Synergistics International, MI, USA. In Ontario, Canada, she held a research associate position in Neurology at the Ottawa University ('95-'98). In the Bronx, she was research associate in Neuropathology at the Albert Einstein College of Medicine ('98-'00), and later joined the New York State Foundation for Psychiatric Research as research scientist at the Nathan S. Kline Institute Dementia Center ('04-'05). At Northwestern University, Chicago, IL, USA, Dr. Zeine was research assistant professor (’06-’07) at the Comprehensive Cancer Center, and later associate director for operation standards and correlative sciences at the Pathology Core Facility (’08) serving the Eastern Cooperative Oncology Group, NCI, USA. Dr. At the University of Chicago, she continued as research faculty on neuroblastoma tumors in pediatric hematology-oncology (’07-’08). At the Saint James School of Medicine (SJSM), IL, USA, Dr. Zeine taught pathology and research in health and medicine, first as assistant professor in Bonaire, Dutch Caribbean ('13-'14), and later as associate professor in St. Vincent and the Grenadines, Eastern Caribbean (’14-‘19). She chaired Quality Assurance and Research committees, and was secretary for Curriculum and Faculty Affairs committees. She was also associate professor at St. Martinus University Faculty of Medicine, Curaçao, Dutch Caribbean (’14). She held workshops on motivational interviewing and breaking bad news, and hosted 12 Science Day events as Science Day coordinator. Her publications span multiple disciplines including effector T cell migration and retention in Experimental Autoimmune (Allergic) Encephalomyelitis, Perforin-mediated gamma-delta T cell cytotoxicity against human Oligodendrocytes in Multiple Sclerosis, Cancer-Associated-Fibroblasts and Microvascular Proliferation in neuroblastoma tumors, joint mobility in sedentary versus active adults, Cyberchondria determinants and impact on patient compliance, Medical Cannabis for Huntington Disease, Multiple Sclerosis, Epilepsy, and Cancers, Congenital Zika Syndrome, organizational behavior in higher education institutions, considerate leadership, external adaptability, mission articulation, customer service focus, employee involvement, empowerment, distribution of influence, total influence, task facilitation, interaction facilitation, job-related stress, motivation and job-satisfaction, personal bases of power and organizational bases of power. Dr. Zeine was included in Marquis’ Who’s Who in America, and has been awarded Teacher Appreciation Recognition from the SGA, Advisor Appreciation Recognition from AMSA, Certificate of Appreciation for Outstanding Accomplishments at SJSM, 8/2019, Emerald Literati Awards for Excellence Outstanding Reviewer (’19) and Outstanding Paper (’21), and Certificate of Appreciation for Community Expertise Mentor from Occupational Therapy (’22) at Kean University, NJ, USA. Currently, Dr. Zeine serves as editorial adviser on textbook materials for Oxford University Press and Macmillan Learning publisher. In 2023, Dr. Zeine released the first scientific book on medical cannabis which she presented to physicians at Boston Children’s Hospital, Harvard Medical School, entitled Zeine R. & Teasdale, B. (Editors). Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinsons and Other Neurodegenerative Diseases. Book, ©2023 IGI Global Publisher, Hershey, PA, USA, pp. 406., and hosted an online FASEB Catalyst Conference entitled Cannabis Mechanisms in Experimental Medicine, attended by participants from 25 countries. On May 2024, Dr. Zeine was invited to speak on Medical Cannabis to an audience in Kuala Lumpur, Malaysia.
Dr. Brian W. Teasdale received his M.S. in Botany from the University of South Florida in 1998 and his Ph.D. in Plant Biology at the University of New Hampshire in 2004. After spending two years at Jacksonville University, he moved to Kean University in 2006 where he has remained and currently serves as both faculty and the Associate Dean of the Dorothy & George Hennings College of Science, Mathematics, and Technology. He specializes in molecular genetics, population genetics, phycology, and medicinal plants. In addition to teaching a specialized course on Cannabis he has worked as a resource in Cannabis biology for the New Jersey Traffic Safety program.

About IGI Global – Publishing Tomorrow’s Research Today
Founded in 1988 and headquartered in Hershey, Pennsylvania, USA, IGI Global is a rapidly growing, mid-sized, independent international academic publisher dedicated to releasing high-quality, peer-reviewed scholarly research publications in the three major academic subject areas of Business & Management, Scientific, Technical, & Medical (STM), and Education. Our commitment is to advance the discovery of pioneering scientific research promptly through swift and agile processes, with books released in approximately 6-9 months from start to finish. With more than 200,000 research collaborations with experts from leading institutions around the world, IGI Global anticipates publishing over 1,000 books in 2025, positioning our publishing output among the industry’s giants with centuries of history. Our Open Access Journal Program includes nearly 200 fully open access journals, making IGI Global one of the largest 100% open access journal publishers in the world. Through traditional book publishing and open access options, IGI Global strives to bring cutting-edge research at the pace of innovation, ensuring that tomorrow’s research is published today.
Learn more about IGI Global here.
Newsroom Contact
Casey Long
(717) 533-8845
Browse for more posts in:
Medical, Healthcare, and Life SciencesBooks & E-Books

No comments Comments

Log in or sign up to comment.
Be the first to comment!

More from IGI Global

Researchers uncover a potential treatment to delay the worst effects of Alzheimer's disease.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesScience & EngineeringBiomedical TechnologiesBooks & E-Books
There is a growing issue in the research community of authors submitting their articles to gold OA journals (and even hybrid OA/subscription-based journals), and then withdrawing their article after it has been accepted to the journal, effectively utilizing all of the resources of that journal, including the peer review, only to then refuse to publish at the end of the process.
Erin WatsonRead More
NewsletterAuthor NewsOpen Access
The sheer amount of plastic waste has become overwhelming and newly proposed laws in California will only make matters worse.
IGI GlobalRead More
Business and ManagementEnvironmental, Agricultural, and Physical SciencesSustainable DevelopmentBooks & E-Books
IGI Global congratulates the winners of this year's Journal Reviewer Award
IGI GlobalRead More
JournalsAwards & RecognitionOpen Access
IGI Global and eContent Pro held an enlightening webinar that offered pointers for researchers, academicians, and professionals looking to increase their chances of having their manuscript accepted into high impact scholarly journals.
IGI GlobalRead More
EducationBusiness and ManagementComputer Science and Information TechnologyJournalsWebinar
Jun 20, 2024 The Right to Read
Oklahoma City school district wins case against the state Board of Education.
IGI GlobalRead More
EducationSocial Sciences and HumanitiesBooks & E-Books
Australian scientists create new bushfire detection method through the use of artificial intelligence and satellites.
IGI GlobalRead More
Environmental, Agricultural, and Physical SciencesScience & EngineeringArtificial IntelligenceBooks & E-BooksResearch Trends
Dr. Zeine has spoken about her research at several events. Most recently, she was a Guest Speaker at the SALIHIN Corporate Centre in Kuala Lumpur, Malaysia, providing insights and background related to the book. See below, where she answers some of our questions about the conception of this research book.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesBooks & E-Books
World Intellectual Property Organization (WIPO) signs first treaty in a decade, discusses link between genetic resources and Indigenous knowledge.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesBooks & E-BooksResearch Trends
First Previous 1 2 3 4 5 6 7 8 9 10  ... Next Last